Patritumab deruxtecan

Synonyms: HER3-DXd

For research use only. Not for use in humans.

Home Biosimilar Antibodies Protein Tyrosine Kinase Others Patritumab deruxtecan

Patritumab deruxtecan (HER3-DXd) is an antibody-drug conjugate (ADC) composed of a fully human anti-HER3 IgG1 monoclonal antibody and a cytotixic topoisomerase I inhibitor. Patritumab deruxtecan shows anticancer activity.

Patritumab deruxtecan

CAS No. 2227102-46-5

Click to purchase products related to Patritumab deruxtecan

Selleck's Patritumab deruxtecan Has Been Cited by 1 Publication

Purity & Quality Control

Batch: D400402 Purity: 99% Protein concentration: 7.497mg/ml Endotoxin Level: ＜1EU/mg
99

Biological Activity

Description Patritumab deruxtecan (HER3-DXd) is an antibody-drug conjugate (ADC) composed of a fully human anti-HER3 IgG1 monoclonal antibody and a cytotixic topoisomerase I inhibitor. Patritumab deruxtecan shows anticancer activity.
  • https://pubmed.ncbi.nlm.nih.gov/35503762/

Product Details

CAS No. 2227102-46-5
ADC antiody Patritumab
ADC cytotoxin Dxd
Formulation 1xPBS
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.